483 Chia Tai Tianqing Pharmaceutical Group Jan 2021

483 Chia Tai Tianqing Pharmaceutical Group Jan 2021

Marijo Kambere FDA$119.00 - Available Now

FDA investigators audited the Chia Tai Tianqing Pharmaceutical Group - Lianyungang, China facility and issued inspectional observations (via FDA 483) on 14 Jan 2021.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Jan 2021
  • Location: Lianyungang, China
  • FEI: 3011860409
Add To Cart